Arcturus therapeutics to report second quarter 2023 financial results and provide corporate update on august 7, 2023

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the company will release its financial results for the quarter and six months ended june 30, 2023 after the market close on monday, august 7th and will also host a conference cal.
ARCT Ratings Summary
ARCT Quant Ranking